Challenges of HPV Vaccination and Prevention
of HPV-related Cancers in Young and Older Adults
A continuing medical
education activity sponsored by NAMCP and AAMCN
Addressing the Challenges of HPV Vaccination and Prevention of HPV-related
Cancers in Young and Older Adults is a two-part webinar series
focusing on the latest developments in the prevention of HPV-related
These are archives of live webinars held between September 16 and
September 18, 2020.
If you participated in any of the live webinars, you are not
claim credit from the archive of that webinar.
By clicking on each of the titles, you will be able to participate
in each part.
It is not required that you participate in all three or in order.
These activities are valid from October 1, 2020 to October 1, 2022
series is supported by an educational grant from Merck Sharp & Dohme
This activity is intended for healthcare professionals practicing in managed
Instructions for CME/NCPD: Complete the pre-test,
listen to the audio and view the slides, complete the post test, complete the
evaluation form and hit submit. You will be asked to enter your name and email
address on the pre-test, evaluation and post-test. If you close your internet
browser without completing the post test, you will have ONE more opportunity to
complete. A score of 70% must be achieved on the post test to receive continuing
education credits. If you do not pass the post test after two attempts, you will
not be eligible to try again. Once you complete the evaluation form and score
70% or higher on your post test, you will automatically be given your
Human papillomavirus (HPV) infection is the most
common sexually transmitted infection in the United States, as well as a cause
of various types of cancer. An estimated 79 million people in the United States
are infected with some type of HPV, and approximately 50% of new infections
occur in individuals before the age of 24. Despite the availability of safe and
effective vaccines, HPV vaccination coverage remains low. There are various
reasons why the vaccination rates are low, including patients' and/or parents'
lack of knowledge about HPV and their discomfort with talking to health care
providers about sexual activity, affordability, among other reasons.
Addressing the Challenges of HPV Vaccination and Prevention of
HPV-related Cancers in Young and Older Adults
Physician, Nursing and CMCN credits valid to
September 1, 2022
- Identify perceived barriers by both healthcare providers and patients to
- Identify disparities and barriers to HPV-associated cancer prevention
across different patient populations
- Assess the efficacy, safety, and utility of HPV vaccination in children,
adolescents, and adults
- Examine strategies to overcome barriers that impede successful
completion of the HPV vaccination series
- Align current clinical practices with key HPV vaccination and cancer